- Home
- / Immuno-Biological Laboratories
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Immuno-Biological Laboratories financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥520
2024-10-29
Market Capitalization
¥4.8 B
2024-10-29
Revenue
¥969.5 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| JPY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 758.3M | 781.2M | 576.7M | 602.7M | 647.6M | 794.6M | 816.7M | 969.5M |
| Cost of goods sold | 281.3M | 320.9M | 359.4M | 255.9M | 270.9M | 267.9M | 299.0M | 325.8M |
| Gross profit | 477.0M | 460.3M | 217.3M | 346.9M | 376.7M | 526.7M | 517.7M | 643.8M |
| Gross profit margin, % | 62.9% | 58.9% | 37.7% | 57.5% | 58.2% | 66.3% | 63.4% | 66.4% |
| Operating expense total | 525.8M | 634.0M | 812.7M | 587.8M | 498.9M | 468.3M | 411.0M | 419.0M |
| Depreciation and amortization | 576.0K | 8.3M | 237.0K | 118.0K | 7.0M | 804.0K | 2.9M | 15.4M |
| EBITDA | (48.8M) | (173.7M) | (685.3M) | (331.9M) | (275.0M) | (145.5M) | 106.6M | 224.8M |
| EBITDA margin, % | -6.4% | -22.2% | -118.8% | -55.1% | -42.5% | -18.3% | 13.1% | 23.2% |
| EBIT | (51.9M) | (184.2M) | (688.5M) | (332.0M) | (281.8M) | (139.7M) | 117.2M | 213.8M |
| EBIT margin, % | -6.8% | -23.6% | -119.4% | -55.1% | -43.5% | -17.6% | 14.4% | 22.1% |
| Interest income | 71.0K | 70.0K | 86.0K | 151.0K | 487.0K | 1.4M | 93.0K | 454.0K |
| Interest expense | 1.8M | 1.3M | 932.0K | 749.0K | 641.0K | 1.1M | 1.1M | 1.3M |
| Pre tax profit | (51.9M) | (164.0M) | (658.7M) | (310.6M) | (250.1M) | (280.6M) | 124.6M | 209.9M |
| Income tax expense | 697.0K | 3.3M | 9.4M | 8.2M | 8.6M | 9.1M | (62.0M) | (39.2M) |
| Net Income | (52.6M) | (167.3M) | (668.1M) | (318.8M) | (258.8M) | (289.7M) | 186.7M | 249.0M |